First Time Loading...

Theratechnologies Inc
TSX:TH

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
TSX:TH
Watchlist
Price: 1.72 CAD 3.61% Market Closed
Updated: May 13, 2024

Theratechnologies Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theratechnologies Inc
Income from Continuing Operations Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Theratechnologies Inc
TSX:TH
Income from Continuing Operations
-$18m
CAGR 3-Years
9%
CAGR 5-Years
-36%
CAGR 10-Years
-7%
Zymeworks Inc
NYSE:ZYME
Income from Continuing Operations
-$118.7m
CAGR 3-Years
13%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Income from Continuing Operations
-$93.8m
CAGR 3-Years
-21%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Income from Continuing Operations
-$94.9m
CAGR 3-Years
-7%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Income from Continuing Operations
-$62.6m
CAGR 3-Years
21%
CAGR 5-Years
0%
CAGR 10-Years
-25%
Spectral Medical Inc
TSX:EDT
Income from Continuing Operations
-CA$15.5m
CAGR 3-Years
-19%
CAGR 5-Years
-44%
CAGR 10-Years
-3%

See Also

What is Theratechnologies Inc's Income from Continuing Operations?
Income from Continuing Operations
-18m USD

Based on the financial report for Feb 29, 2024, Theratechnologies Inc's Income from Continuing Operations amounts to -18m USD.

What is Theratechnologies Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-7%

Over the last year, the Income from Continuing Operations growth was 63%. The average annual Income from Continuing Operations growth rates for Theratechnologies Inc have been 9% over the past three years , -36% over the past five years , and -7% over the past ten years .